August 2, 2023
Taiho Pharmaceutical said on August 1 that its French partner Servier has won European regulatory approval for Lonsurf (trifluridine + tipiracil) in combination with bevacizumab for the third-line treatment of metastatic colorectal cancer (mCRC). The European Commission gave the thumbs-up...read more